Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Lower Out of Pocket Drug ... the IRA of 2022 so that seniors would pay $35 at the pharmacy for their covered insulin. In 2025 ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Then, in 2022 – in a blaze of stardust – the GLP-1 agonist drugs arrived on the scene. These medications had been used for ...

Jelly Roll is keeping the nickname he's had since childhood, but his newfound focus on his health has the 2024 CMA Awards nominee altering his relationship with food and feeling better than ever.

Eli Lilly's Mounjaro joins list of obesity and diabetes drugs made popular by celebrities who lost weight The latest ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

The new weight-loss drugs have created ... an early-generation GLP-1 drug—cut BMI by at least 5 percent in most participants after 56 weeks. A 2022 trial of 201 teens aged 12 to 18 reported ...